These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3608898)

  • 1. [Favorable action of preliminary fasting on changes in liver plasma membrane enzymes due to the use of D-galactosamine].
    Adzharov D; Dimov S; Savov G; Naĭdenova E; Petrova S
    Eksp Med Morfol; 1987; 26(2):20-3. PubMed ID: 3608898
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in glycoproteins of liver plasma membranes from rats treated with D-galactosamine.
    Bertrand F; Veissiere D; Picard J
    Digestion; 1979; 19(5):284-91. PubMed ID: 488550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic defence against oxygen toxicity in D-galactosamine-induced hepatitis in rats.
    D'Souza NB; Kulkarni AB; Baxi AJ; Nadkarni GD
    Indian J Gastroenterol; 1985 Apr; 4(2):87-8. PubMed ID: 3845914
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacologic regulation of hepatocyte cytolysis by antioxidants during acute D-galactosamine hydrochloride intoxication].
    Vinogradova LF; Illarionova TS; Kharlitskaia EV; Burobina SS; Berezov TT
    Biull Eksp Biol Med; 1998 Apr; 125(4):417-9. PubMed ID: 9631725
    [No Abstract]   [Full Text] [Related]  

  • 5. [Morphological characteristics of D-galactosamine hepatitis].
    Popov A; Klouchek-Popova E; Stoilova M
    Eksp Med Morfol; 1983; 22(2):74-80. PubMed ID: 6667658
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of preliminary fasting on the development of D-galactosamine-induced acute lesion of the liver in rats].
    Adzharov D; Donchev N; Kerimova M; Naĭdenova E; Borov B
    Biull Eksp Biol Med; 1989 Jan; 107(1):33-6. PubMed ID: 2914170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental research on the hepatoprotective activity of drug combinations].
    Drenska D; Ovcharov R; Klouchek E; Popov A
    Eksp Med Morfol; 1985; 24(1):54-9. PubMed ID: 4029071
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of disulfiram on function of the liver of rats with galactosamine-induced hepatitis.
    Mach T
    Pol J Pharmacol Pharm; 1986; 38(3):235-41. PubMed ID: 3095801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regenerative enzyme activity of the liver after partial hepatectomy or toxic injury depressed by continuous NH4+ infusion.
    Zieve L
    J Lab Clin Med; 1989 Nov; 114(5):527-30. PubMed ID: 2809396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK 506 modulates D-galactosamine-induced hepatitis in rats.
    Farghali H; Gasbarrini A; Borle AB; Nalesnik MA; Francavilla A; Fagiuoli S; Starzl TE; Van Thiel DH
    Transplant Proc; 1991 Dec; 23(6):2809-11. PubMed ID: 1721285
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacies of whole blood and plasma cross circulation on galactosamine induced hepatic failure rats.
    Okabe K; Ouchi K; Koyama K; Sato T
    Trans Am Soc Artif Intern Organs; 1984; 30():395-8. PubMed ID: 6533913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine].
    Reutter W; Bachmann W
    Verh Dtsch Ges Inn Med; 1971; 77():1177-8. PubMed ID: 5155984
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of DBcAMP on galactosamine-induced acute liver failure].
    Kakisaka A; Kasai S; Sawa M
    Nihon Geka Gakkai Zasshi; 1986 May; 87(5):581. PubMed ID: 3012316
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatoprotective effect of silymarin (carsil) on liver of D-galactosamine treated rats. Biochemical and morphological investigations.
    Tyutyulkova N; Tuneva S; Gorantcheva U; Tanev G; Zhivkov V; Chelibonova-Lorer H; Bozhkov S
    Methods Find Exp Clin Pharmacol; 1981; 3(2):71-7. PubMed ID: 7230979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of ubiquinone-10 on the development of D-galactosamine-induced hepatitis in rats].
    Sugrobova NP; Medvednik RS; Efimova LV; Katarzhnova TV; Liubarev AE; Shaposhnikov VM; Obol'nikova EA; Poznanskaia AA
    Biull Eksp Biol Med; 1992 Nov; 114(11):504-6. PubMed ID: 1290824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thiamine diphosphate pool and its biosynthesis in the liver in galactosamine hepatitis].
    Trebukhina RV; Moiseenok AG; Petushok VG; Tumanov VN; Gorenshteĭn BI; Sheĭbak VM; Omel'ianchik SN
    Ukr Biokhim Zh (1978); 1989; 61(4):73-7. PubMed ID: 2588337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early, reversible plasma membrane injury in galactosamine-induced liver cell death.
    El-Mofty SK; Scrutton MC; Serroni A; Nicolini C; Farber JL
    Am J Pathol; 1975 Jun; 79(3):579-96. PubMed ID: 1137005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Function of lysosomal enzymes in galactosamine hepatitis].
    Heissmeyer H; Stein U
    Verh Dtsch Ges Inn Med; 1972; 78():1377-80. PubMed ID: 4665551
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of pretreatment of rats with uracil on liver injuries induced by D-galactosamine and allyl alcohol.
    Kitajima S; Ogawa N; Ariyoshi T
    Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):14-20. PubMed ID: 7953190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.